ARCHIVES

Oral Combination Provides Alternative To IV Chemo For Multiple Myeloma

This article is from The Cancer Letter archive.

Vol. 25 No. 11 | November 29, 2002

Download PDF Visit The Full Archive

Related Articles

Drug Development: Tivozanib Trial Discontinued Due to Insufficient Enrollment

February 7, 2014

In Brief: Peter Fischinger Names NCI Deputy Director; ACR Moves Headquarters To Washington Area

November 8, 1985

PDQ Out of Business Of Setting Guidelines For Cancer Screening

September 17, 1993

Stop Cancer Still Working To Raise Funds

March 22, 1991

Columbia To Host U.S.- China Conference

February 15, 1980

Study: End-of-Life Chemotherapy Leads to More Deaths in Hospital

March 28, 2014